亚洲 · 综合新闻 · China Daily
Wuxi-developed cancer drug reaches US market
D3 Bio is advancing four drug candidates through global clinical trials, while Abogen Biosciences signed a licensing agreement with Swiss pharmaceutical giant Novartis in October,…
在 China Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (global.chinadaily.com.cn)


